SCHEMBL29633710

SCHEMBL29633710

CNC(Cc1cncc(OC)c1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.44
CYP11B2 P19099 3/20 0.44
KCNH2 Q12809 1/20 0.42
FPR2 P25090 1/20 0.40
LDHA P00338 1/20 0.40
CA2 P00918 1/20 0.39
ALDH1A1 P00352 1/20 0.39
ALOX15 P16050 1/20 0.39
KDM1A O60341 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
KMT2A Q03164 1/20 0.38
PTGDR Q13258 1/20 0.38
PPARG P37231 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29633844 0.86 CYP11B1 (0.42) CYP11B1CYP11B2KCNH2KDM1AMAOA
SCHEMBL21879107 0.81 ACE (0.53) PPARG
SCHEMBL21879106 0.81 ACE (0.53) PPARG
SCHEMBL26008462 0.81 CTSB (0.49) CYP11B1CYP11B2PPARG
SCHEMBL22444712 0.79 TPH1 (0.46) ALDH1A1ALOX15KMT2APPARG
SCHEMBL25361477 0.79 HCAR2 (0.41)
SCHEMBL22444674 0.79 HCAR2 (0.41)
SCHEMBL31754334 0.79 HCAR2 (0.41) CYP11B1CYP11B2ALDH1A1PPARG
SCHEMBL22444676 0.79 CASP3 (0.48) FPR2ALDH1A1ALOX15
SCHEMBL22444732 0.79 HCAR2 (0.41) CYP11B1CYP11B2ALDH1A1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2024-11-14 US disclosed
US-12071396-B2 Method for preparing aromatic amino acid derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-08-27 US disclosed
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR CYP11B1 1294/4885CYP11B2 866/4885KCNH2 1976/4885
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR CYP11B1 1294/4885CYP11B2 866/4885KCNH2 1976/4885
US-12071396-B2 Method for preparing aromatic amino acid derivative DDC, AADAT, TYR CYP11B1 1294/4885CYP11B2 866/4885KCNH2 1976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.